跳至主要内容
临床试验/ACTRN12615001305516
ACTRN12615001305516进行中(未招募)3 期

Feasibility of Nasal High therapy and standard practice for Infants and Children with Acute Respiratory Failure

ady Cilento Children's Hospital0 个研究点目标入组 576 人开始时间: 2015年11月30日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
576

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 16 Years(—)
性别
All

入选标准

  • Children aged 0-16 years of age with the clinical diagnosis of an Acute Hypoxemic Respiratory Failure disease process such as acute lower respiratory tract infection or asthma, or pnuemonia as examples, and an oxygen requirement in room air (SpO2 <92%)
  • Included are infants with reactive airway disease >12 months and an oxygen requirement in room air (SpO2 <92%). This includes infants >12 months with the diagnosis of bronchiolitis.
  • Informed consent from parents or guardians

排除标准

  • Upper airway obstruction
  • Craniofacial malformations
  • Critically ill infants requiring immediate higher level of respiratory support i.e. NIV or invasive ventilation, low level of consciousness.
  • Basal skull fracture
  • Cyanotic Heart Disease
  • Home Oxygen therapy
  • Apnoeas (defined as requiring respiratory support such as NIV or mechanical ventilation)
  • Upper airway obstruction
  • Cystic Fibrosis
  • Oncology patients
  • Palliative Care patients
  • Previous use of NHF therapy
  • Child protection case

研究者

发起方
ady Cilento Children's Hospital

相似试验